Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study

Context: Recently biomarkers for sleep disorders have provided an alternative and convenient means of diagnosis for children at risk. Aim: To evaluate salivary TNF-α and Malondialdehyde (MDA) levels in children with skeletal class II malocclusion and with a positive history of sleep disorders. Setti...

Full description

Bibliographic Details
Main Authors: Nagashree Prabhu, Vabitha Shetty
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Dental Research
Subjects:
Online Access:http://www.ijdr.in/article.asp?issn=0970-9290;year=2022;volume=33;issue=1;spage=18;epage=23;aulast=Prabhu
_version_ 1811275830167339008
author Nagashree Prabhu
Vabitha Shetty
author_facet Nagashree Prabhu
Vabitha Shetty
author_sort Nagashree Prabhu
collection DOAJ
description Context: Recently biomarkers for sleep disorders have provided an alternative and convenient means of diagnosis for children at risk. Aim: To evaluate salivary TNF-α and Malondialdehyde (MDA) levels in children with skeletal class II malocclusion and with a positive history of sleep disorders. Settings and Design: This prospective evaluative study was carried out from October 2020 to March 2021, in the Department of Pediatric and Preventive Dentistry. Material and Methods: 21 children aged 8-12 years with skeletal class II malocclusion and at least one sleep disorder participated in the study (Group 1). 21 age and gender matched children with no skeletal malocclusion and no reported history of sleep disorders served as a comparison group (Group 2). All children were evaluated regarding their sleep history and clinically examined to determine craniofacial morphology. Unstimulated saliva was collected from all children. Salivary TNF-α was measured with a solid-phase sandwich ELISA. Salivary MDA was measured by using TBA reagent. Statistical Analysis: Intergroup comparison for age and normally distributed data was done using t-test. Comparison of frequencies of categories of variables was done using Chi-square test. Inter group comparison for TNF-α was done using Mann–Whitney U test. Results: There were significantly higher levels of salivary TNF-α and MDA, in children of Group 1 when compared to that of Group 2 children (p < 0.01). Conclusion: Salivary TNF-α and MDA may be a simple and non-invasive tool in the identification and screening of children at high risk for sleep disorders.
first_indexed 2024-04-12T23:45:39Z
format Article
id doaj.art-53d9a624c8be4c7c9a583725e7b6f1e7
institution Directory Open Access Journal
issn 0970-9290
1998-3603
language English
last_indexed 2024-04-12T23:45:39Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Dental Research
spelling doaj.art-53d9a624c8be4c7c9a583725e7b6f1e72022-12-22T03:11:52ZengWolters Kluwer Medknow PublicationsIndian Journal of Dental Research0970-92901998-36032022-01-01331182310.4103/ijdr.ijdr_1103_21Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative studyNagashree PrabhuVabitha ShettyContext: Recently biomarkers for sleep disorders have provided an alternative and convenient means of diagnosis for children at risk. Aim: To evaluate salivary TNF-α and Malondialdehyde (MDA) levels in children with skeletal class II malocclusion and with a positive history of sleep disorders. Settings and Design: This prospective evaluative study was carried out from October 2020 to March 2021, in the Department of Pediatric and Preventive Dentistry. Material and Methods: 21 children aged 8-12 years with skeletal class II malocclusion and at least one sleep disorder participated in the study (Group 1). 21 age and gender matched children with no skeletal malocclusion and no reported history of sleep disorders served as a comparison group (Group 2). All children were evaluated regarding their sleep history and clinically examined to determine craniofacial morphology. Unstimulated saliva was collected from all children. Salivary TNF-α was measured with a solid-phase sandwich ELISA. Salivary MDA was measured by using TBA reagent. Statistical Analysis: Intergroup comparison for age and normally distributed data was done using t-test. Comparison of frequencies of categories of variables was done using Chi-square test. Inter group comparison for TNF-α was done using Mann–Whitney U test. Results: There were significantly higher levels of salivary TNF-α and MDA, in children of Group 1 when compared to that of Group 2 children (p < 0.01). Conclusion: Salivary TNF-α and MDA may be a simple and non-invasive tool in the identification and screening of children at high risk for sleep disorders.http://www.ijdr.in/article.asp?issn=0970-9290;year=2022;volume=33;issue=1;spage=18;epage=23;aulast=Prabhubiomarkerchildrenmalondialdehydesleep disorderstumor necrosis factor-alpha
spellingShingle Nagashree Prabhu
Vabitha Shetty
Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study
Indian Journal of Dental Research
biomarker
children
malondialdehyde
sleep disorders
tumor necrosis factor-alpha
title Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study
title_full Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study
title_fullStr Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study
title_full_unstemmed Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study
title_short Salivary tumor necrosis factor–Alpha and malondialdehyde levels in children with class II malocclusion and sleep disorders: An evaluative study
title_sort salivary tumor necrosis factor alpha and malondialdehyde levels in children with class ii malocclusion and sleep disorders an evaluative study
topic biomarker
children
malondialdehyde
sleep disorders
tumor necrosis factor-alpha
url http://www.ijdr.in/article.asp?issn=0970-9290;year=2022;volume=33;issue=1;spage=18;epage=23;aulast=Prabhu
work_keys_str_mv AT nagashreeprabhu salivarytumornecrosisfactoralphaandmalondialdehydelevelsinchildrenwithclassiimalocclusionandsleepdisordersanevaluativestudy
AT vabithashetty salivarytumornecrosisfactoralphaandmalondialdehydelevelsinchildrenwithclassiimalocclusionandsleepdisordersanevaluativestudy